ASCLS eNewsBytes

• Blood-Based Screening Has Acceptable Accuracy for Colorectal Cancer Detection June 16, 2025
  A study published in the Journal of the American Medical Association found that blood-based tests have acceptable accuracy for detecting colorectal cancer, but not for advanced precancerous lesions.
• FDA Approval of Pembrolizumab Marks Major Shift in Head and Neck Cancer Treatment June 16, 2025
  FDA approves Pembrolizumab for treating resectable squamous cell carcinoma patients with PD-L1 tumors, based on KEYNOTE-689 study data showing longer event-free survival and higher rates of substantiation.
• Rapid Generation of Functional Blood Vessels From Human Stem Cells June 16, 2025
  Researchers have developed a fast, efficient method to create 3D microvascular nets from stem cells, improving the efficiency and complexity of blood vessel creation.
• A Robust and Scalable Framework for Hallucination Detection in Virtual Tissue Staining and Digital Pathology June 16, 2025
  Advances in virtual tissue staining technologies, using artificial intelligence, offer multiplexed staining and tissue preservation, but concerns about potential hallucinations and artefacts persist, necessitating autonomous quality assessment.
• FDA-Approved Blood Test Detects Early Markers of Alzheimer's Disease June 16, 2025
  A blood test approved by the FDA offers an inexpensive, noninvasive method for detecting biomarkers of Alzheimer's disease, enhancing early detection and treatment opportunities.